IRLAB Therapeutics (OMX: IRLAB-A)

Last close As at 27/02/2026

SEK1.72

−0.01 (−0.35%)

Market capitalisation

Edison Investment Research has terminated coverage on IRLAB Therapeutics (IRLAB-A). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.

Latest Insights

View More
IRLAB Therapeutics_resized

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Kristina Torfgård

    CEO

  • Kristina Torfgård

    CEO

  • Viktor Siewertz

    CFO

Thematics